EHMT2 gains/amplifications (≥3 copies) are found in 25.8% of melanomas and 21.1% of colorectal patients (Figure 1B, TCGA PanCancer Atlas Colorectal Adenocarcinoma). This evidence concerns the gene EHMT2 and colorectal adenocarcinoma.